Physician profile
Fadi Farah
NPI 1760814933
$6,198.18
in general payments reported to CMS, 2019-2025
24 companies · $191 in 2025
The $191 reported for 2025 was more than what 80% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $372 · 2020: $1,241 · 2021: $242 · 2022: $799 · 2023: $2,162 · 2024: $1,190 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,856 · Travel and Lodging: $1,688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,855.94 |
| Travel and Lodging | $1,687.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,404.89 | 2021-2025 | Osteocool Rf Ablation System, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Relievant Medsystems, INC. | $1,110.33 | 2022-2023 | Intracept |
| Medtronic USA, INC. | $1,024.62 | 2020 | |
| Si-Bone, INC. | $882.24 | 2024 | |
| Boston Scientific Corporation | $577.73 | 2019-2024 | Wavewriter Alpha Prime 16, Avista Mri |
| Abbott Laboratories | $282.74 | 2019-2025 | Proclaim, Octrode |
| Avanos Medical | $139.70 | 2020-2021 | |
| Vertos Medical, INC. | $110.35 | 2023-2024 | Mild Device Kit |
| Stryker Corporation | $98.97 | 2021-2023 | Spinejack |
| Pacira Pharmaceuticals Incorporated | $73.19 | 2021-2022 | |
| Mml US, INC. | $69.72 | 2023 | Reactiv8 |
| Bioventus LLC | $60.64 | 2023 | Stimrouter Implantable Kit |
| Nevro Corp. | $50.49 | 2022-2024 | Senza |
| Saluda Medical Americas, INC. | $47.52 | 2025 | Evoke |
| Novo Nordisk INC | $43.22 | 2023-2025 | Rybelsus, Ozempic |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acacia Pharma INC | $42.76 | 2021 | |
| Biotronik Nro, INC. | $41.32 | 2025 | Prospera |
| Zimmer Biomet Holdings, INC. | $33.89 | 2023 | Gps III Platelet Concentration System |
| Grt US Holding, INC. | $23.89 | 2021 | |
| Curonix LLC | $21.31 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Tonix Medicines, INC. | $17.60 | 2025 | Tonmya |
| Stimwave Technologies Incorporated | $14.53 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $13.68 | 2021 | |
| Allergan, INC. | $12.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fadi Farah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.